Endonorm®

Эндонорм®

About the product

Trade name: Endonorm®

Dosage form: capsules

Ingredients: each capsule contains: white cinquefoil root extract – 200 mg; tripartite beggarticks herb extract – 80 mg; licorice root extract – 50 mg; sugar kelp powder – 70 mg

For the patient

Dietary supplement: Endonorm®

Indications for use:

Recommended as an additional source of glycyrrhizic acid, tannins, and iodine

  • Hypothyroidism of various origins
  • Treatment of nodular (multinodular) colloid goiter
  • Autoimmune thyroiditis

Helps restore the functional activity and morphological structure of the thyroid gland, and has a beneficial effect when used as part of complex therapy for hyperplastic disorders of the female reproductive system

Consultation with a healthcare professional is recommended before use

Contraindications:

  • Individual intolerance to the components
  • Pregnancy
  • Breastfeeding

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.